PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 2, 2019Expert Review of Vaccines48 citationsOpen Access

The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series

DCDaniel CaldeiraBRBárbara RodriguesCDCláudio David

Structured PICO

Does influenza infection or vaccination alter the short-term risk of myocardial infarction?

P
Population
Patients from 5 self-controlled case series studies (3 evaluating influenza infection, 2 evaluating influenza vaccination)
I
Intervention
Influenza infection and influenza vaccination
C
Comparator
Self-controlled baseline periods (periods without recent influenza infection or vaccination)
O
Outcome
Risk of myocardial infarction (MI)hard clinical

Influenza infection significantly increases the short-term risk of myocardial infarction, whereas influenza vaccination is safe and associated with a short-term decrease in MI risk, though potentially influenced by healthy period bias.

Limitations

  • Low-to-moderate confidence in the pooled evidence for infection
  • Risk reduction with vaccination is possibly related to a healthy period bias

Abstract

Introduction: Influenza vaccination may be beneficial in coronary disease patients; however the infection and vaccination are associated with acute inflammation, a trigger of cardiovascular events. We aimed to review the risk of myocardial infarction (MI) associated with Influenza infection and the safety of vaccination in self-controlled case series (SCCS).Methods: We performed a systematic review with meta-analysis of SCCS studies to evaluate the risk of MI associated with Influenza infection/vaccination. Database search was performed in August/2018. The data were reported using the incident rate ratio (IRR) and 95% confidence interval (95%CI).Results: three studies for Influenza infection and two studies for Influenza vaccination were eligible. The risk of MI following an Influenza infection was significantly increased in the first 3 days (IRR 5.79; 95%CI: 3.59–9.38) and between 4-7 days (IRR 4.52; 95%CI: 2.80–7.32). In the first 4 weeks following the Influenza vaccination, there was a significant decrease of MI risk (IRR 0.84, 95%CI: 0.78–0.91).Conclusions: Short-term MI risk in Influenza infection is significantly increased, with a low-to-moderate confidence in the pooled evidence. The Influenza vaccine was safe regarding the short-term risk for MI, and the risk reduction is possibly related to a healthy period bias.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Caldeira et al. (2019) studied this question.

synapsesocial.com/papers/69d570ca75589c71d767df3ahttps://doi.org/10.1080/14760584.2019.1690459
Ask AI
Helpful
Bookmark
Share
View Full Paper